SANASPE

Active

Private limited companyfounded 2005active for 21 yearsWilstraat 1, 1070 Anderlecht, BelgiumKBO/BCE: BE 0874.832.607

From the official registers: KBO 18 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of SANASPE is 1.8% (moderate). The 2025 annual accounts show equity of €40,739 and a net result of €12,455. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 32% of 22,679 sector peers (NACE 47, financial year 2025). The company has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

SANASPEActiveChecked score 55/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 04-07-2005 Normal situation
Legal form: Private limited company
Registered office: Wilstraat 1, 1070 Anderlecht
Activity: Retail sale of pharmaceutical products NACE 47730
Establishment units: 2.000.436.839 1070 Anderlecht, since 01-04-1966
: 2.152.102.376 1070 Anderlecht, since 16-01-2006
Financial year end: 30 June
Peppol: Reachable since 14-04-2026

Company details

Who decides

Board

SIMBI SabineDirector · since 18-03-2022
ATETE ArletteDirector · since 18-03-2022

Board & ownership

How it is doing

55 Fair Checked score 2025

Bankruptcy probabilitywithin 12 months: 1.8%

Annual accounts to 30-06-2025

Turnover: €63,129; ▼ 35.9%
Profit: €12,455; ▼ 6.9%
Equity: €40,739; ▲ 30.2%
Total assets: €305,664; ▲ 2.9%

2025 accounts filed 3 days late

Filed on 03-02-2026PDF

Financials

Why 55raises riskLast filed accounts filed 4 days late; 2 of the last 3 lateLiquidity: current ratio 1.70lowers riskFounded in 2005Size: turnover €63,129, total assets €305,664Show the evidence

Checked score

Score 2025

55 / 100

Fair

Probability in this band: 1.5% to 4.2%

Financially better than 55% of its sector peers (NACE 47, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 38+2

equity 13.3% of total assets

Liquidity 93+1

short-term debt 15.7%

Profitability 72-10

return on assets 4.1%

Bankruptcy probability, 12 months

1.8% Moderate

0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)

Last 24 months 11-2024: 1.8% 12-2024: 1.7%▼ -0.1 percentage points vs 11-2024lowest value 01-2025: 2.1%▲ +0.4 percentage points vs 12-2024 02-2025: 2.7%▲ +0.6 percentage points vs 01-2025 03-2025: 3.0%▲ +0.3 percentage points vs 02-2025 04-2025: 3.8%▲ +0.8 percentage points vs 03-2025 05-2025: 4.1%▲ +0.3 percentage points vs 04-2025 06-2025: 5.2%▲ +1.1 percentage points vs 05-2025 07-2025: 8.9%▲ +3.7 percentage points vs 06-2025highest value 08-2025: 8.8%▼ -0.1 percentage points vs 07-2025 09-2025: 3.5%▼ -5.3 percentage points vs 08-2025 10-2025: 3.6%▲ +0.1 percentage points vs 09-2025 11-2025: 3.6%● unchanged vs 10-2025 12-2025: 3.2%▼ -0.4 percentage points vs 11-2025 01-2026: 3.4%▲ +0.2 percentage points vs 12-2025 02-2026: 4.0%▲ +0.6 percentage points vs 01-2026 03-2026: 1.8%▼ -2.2 percentage points vs 02-2026 04-2026: 1.8%● unchanged vs 03-2026 05-2026: 1.8%● unchanged vs 04-2026 06-2026: 1.8%● unchanged vs 05-2026 07-2026: 1.9%▲ +0.1 percentage points vs 06-2026 08-2026: 1.9%● unchanged vs 07-2026 09-2026: 1.9%● unchanged vs 08-2026 10-2026: 1.8%▼ -0.1 percentage points vs 09-2026

Credit of up to €2,000 on 30-day terms is acceptable

Liquidity ample (current ratio 1.7, compared with 1.3 in 2024, above the usual 1.5; short-term debt: 15.7% of total assets), but 86.7% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 30% on solvency, 93% on liquidity, 55% on profitability and 44% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises risk

Last filed accounts filed 4 days late; 2 of the last 3 late

NBB · filings

Liquidity: current ratio 1.70

NBB · annual accounts

Founded in 2005

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Size: turnover €63,129, total assets €305,664

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Growing equity

Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.

NBB · annual accounts 2025

Equity per financial year

19202122232425

2019 to 2025 · latest year €40,739

2025 accounts filed 3 days late

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 03-02-2026, 3 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

3 days late

2024

199 days late

2023

55 days late

2022

36 days late

2021

23 days late

2020

18 days early

2019

46 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 36 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 8 March (4 of the last 5 filed years within 33 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-06-2026 year end01-11-2026 today31-01-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Documents

Key facts about SANASPE

What is the company number of SANASPE?: 0874.832.607. In Belgium the VAT number is the company number with BE in front: BE 0874.832.607.
Where is SANASPE based?: The registered office is at Wilstraat 1, 1070 Anderlecht.Company details
What does SANASPE do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of SANASPE?: Private limited company (BV).
When was SANASPE founded?: On 04-07-2005.
Is SANASPE still active?: Yes, SANASPE is an active enterprise in the KBO register.
What is the turnover of SANASPE?: €63,129 in financial year 2025, according to the filed annual accounts.Financials
Is SANASPE profitable?: In financial year 2025, SANASPE made a profit of €12,455.
Where can I find the annual accounts of SANASPE?: SANASPE filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of SANASPE due?: By 31-01-2027, for financial year 2026.Timeline